Register now to our Newsletter

New financing round will enable the company to accelerate its growth and expand its international services offers.

TransCure bioservices is pleased to announce that we have received full AAALAC Accreditation

We from TCS are leveraging our human immune system models and knowledge to assist our customer in the fight against SARS-Cov2

Find out the details on how TransCure bioServices will improve human liver diseases research and development with its novel and innovative human hepatocytes (hu-liver) mouse models.

Webinar 2020 Sessions, hosted by Sebastien Tabruyn, PhD, CSO will be reconducted in 2021. Stay tuned.

We welcome our new scientific writer and project manager. Take a moment to know them.

Our animal facility is evolving relying on a 4500+ mouse capacity and cutting-edge humanized models and running more than 500 humanizations per month.

We welcome our new scientific writer and project manager. Take a moment to know them.

Our team is -giving the current circumstances- still working on full speed for our international customers and we´ve implemented the strictest rules to reduce the impact of SARS-COV-2 on our company employees and management.